Recent Analyst Forecasts and Stock Ratings
ArriVent BioPharma, Inc. Common Stock FAQ's
ArriVent BioPharma, Inc. Common Stock has been rated by research analysts at Truist Financial, Goldman Sachs, Citigroup, H.C. Wainwright, Oppenheimer in the past 90 days.